Cargando…

The effects of additional treatment with terguride, a partial dopamine agonist, on hyperprolactinemia induced by antipsychotics in schizophrenia patients: a preliminary study

Hyperprolactinemia is a frequent consequence of treatment with antipsychotics. Earlier studies have indicated that terguride, which is a partial dopamine agonist, reduces the prolactin levels that are induced by prolactinemia. Thus, we examined the dose effects of adjunctive treatment with terguride...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hashimoto, Kojiro, Sugawara, Norio, Ishioka, Masamichi, Nakamura, Kazuhiko, Yasui-Furukori, Norio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149438/ https://www.ncbi.nlm.nih.gov/pubmed/25187719 http://dx.doi.org/10.2147/NDT.S68298

Ejemplares similares

Hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers
por: Ishioka, Masamichi, et al.
Publicado: (2015)

Attitudes toward long-acting injectable antipsychotics among patients with schizophrenia in Japan
por: Sugawara, Norio, et al.
Publicado: (2019)

Hypoprolactinemia and hyperprolactinemia in male schizophrenia patients treated with aripiprazole and risperidone and their relationships with testosterone levels
por: Tasaki, Minami, et al.
Publicado: (2021)

PM399. Attitudes toward antipsychotic long-acting injections among patients with Schizophrenia in Japan.
por: Kudo, Shuhei, et al.
Publicado: (2016)

Dietary patterns are associated with obesity in Japanese patients with schizophrenia
por: Sugawara, Norio, et al.
Publicado: (2014)

PS108. Characteristics of escitalopram discontinuation syndrome
por: Norio-Furukori, Yasui, et al.
Publicado: (2016)

Recent trends in antipsychotic polypharmacy in the treatment of schizophrenia
por: Yasui‐Furukori, Norio, et al.
Publicado: (2020)

PS104. An attempt to construct a 7-item short version of the Temperament and Character Inventory to predict the treatment response of patients with depression
por: Tomito, Tetsu, et al.
Publicado: (2016)

Parental bonding and attitudes toward suicide among medical college students in Japan
por: Hashimoto, Kojiro, et al.
Publicado: (2014)

Attitudes toward Placebo-Controlled Clinical Trials of Patients with Schizophrenia in Japan
por: Sugawara, Norio, et al.
Publicado: (2015)

An attempt to construct a 7-item short version of the temperament and character inventory to predict the treatment response of patients with depression; a validation study
por: Tomita, Tetsu, et al.
Publicado: (2016)

Effects of Antipsychotics on Arrhythmogenic Parameters in Schizophrenia Patients: Beyond Corrected QT Interval
por: Okayasu, Hiroaki, et al.
Publicado: (2021)

Competence to Consent and Its Relationship With Cognitive Function in Patients With Schizophrenia
por: Sugawara, Norio, et al.
Publicado: (2019)

The Yamaguchi fox/pigeon-imitation test, a brief cognitive performance rating tool, in a community-dwelling population: normative data for Japanese subjects – a preliminary study
por: Ishioka, Masamichi, et al.
Publicado: (2014)

The low level of understanding of depression among patients treated with antidepressants: a survey of 424 outpatients in Japan
por: Kudo, Shuhei, et al.
Publicado: (2015)

Timing of psychoeducation for patients with depression who were treated with antidepressants: when should patients receive psychoeducation
por: Tomita, Tetsu, et al.
Publicado: (2018)

The characteristics of understanding of depression among older patients treated with antidepressants: a comparison between older and younger patients
por: Tomita, Tetsu, et al.
Publicado: (2018)

Sex Differences In Psychoeducation For Patients With Depression: A Comparison Of Frequency And Efficacy Of Psychoeducation
por: Tomita, Tetsu, et al.
Publicado: (2019)

Differences in etiological beliefs about schizophrenia among patients, family, and medical staff
por: Tarakita, Natsumi, et al.
Publicado: (2018)

Differences in self‐reported psychotic symptoms between patients with autism spectrum disorder and those with schizophrenia
por: Yamada, Momoka, et al.
Publicado: (2023)

The Influence of 5-HTTLPR Genotype on the Association between the Plasma Concentration and Therapeutic Effect of Paroxetine in Patients with Major Depressive Disorder
por: Tomita, Tetsu, et al.
Publicado: (2014)

Dietary patterns and schizophrenia: a comparison with healthy controls
por: Tsuruga, Koji, et al.
Publicado: (2015)

Reversal of symptomatic antipsychotic-induced hyperprolactinemia with addition of aripiprazole
por: Kotorki, Paraskevi, et al.
Publicado: (2010)

Different Attitudes of Patients and Psychiatrists Toward Benzodiazepine Treatment
por: Kawamata, Yasushi, et al.
Publicado: (2021)

Comparison of predictive equations for resting energy expenditure among patients with schizophrenia in Japan
por: Sugawara, Norio, et al.
Publicado: (2014)

Body mass index and quality of life among outpatients with schizophrenia in Japan
por: Sugawara, Norio, et al.
Publicado: (2013)

Update on the development of lurasidone as a treatment for patients with acute schizophrenia
por: Yasui-Furukori, Norio
Publicado: (2012)

Treatment Discontinuation Among Patients with Schizophrenia Treated with Brexpiprazole and Other Oral Atypical Antipsychotics in Japan: A Retrospective Observational Study
por: Hishimoto, Akitoyo, et al.
Publicado: (2022)

Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin)
por: Kelly, Deanna L, et al.
Publicado: (2013)

Effects of personality on the association between paroxetine plasma concentration and response
por: Tomita, Tetsu, et al.
Publicado: (2018)

High-density lipoprotein-cholesterol and antipsychotic medication in overweight inpatients with schizophrenia: post-hoc analysis of a Japanese nationwide survey
por: Ono, Shin, et al.
Publicado: (2018)

Management of antipsychotic-induced hyperprolactinemia
por: Tewksbury, Ashley, et al.
Publicado: (2016)

Interaction between paliperidone extended release and TS-1(®), an oral anticancer drug containing a 5-fluorouracil derivative, in a schizophrenic patient
por: Yasui-Furukori, Norio, et al.
Publicado: (2013)

Meta-analysis: the effects of smoking on the disposition of two commonly used antipsychotic agents, olanzapine and clozapine
por: Tsuda, Yoshiyuki, et al.
Publicado: (2014)

Comparing the influences of age and disease on the Brief Assessment of Cognition in Schizophrenia in Japanese patients with schizophrenia
por: Kaneda, Ayako, et al.
Publicado: (2013)

Comparison of prevalence of metabolic syndrome in hospital and community-based Japanese patients with schizophrenia
por: Sugawara, Norio, et al.
Publicado: (2011)

Projections of psychiatrists’ distribution for patients in Japan: a utilization-based approach
por: Sugawara, Norio, et al.
Publicado: (2021)

Psychiatrists' Attitudes toward Metabolic Adverse Events in Patients with Schizophrenia
por: Sugawara, Norio, et al.
Publicado: (2014)

Hyperprolactinemia with Antipsychotic Drugs in Children and Adolescents
por: Rosenbloom, Arlan L.
Publicado: (2010)

Antipsychotics-induced hyperprolactinemia and screening for macroprolactin
por: Ruljancic, Nedjeljka, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_laa2chglt5kkkt2r1k2u2hv1j2